ROBERT ALEXANDER INGRAM - 07 Jun 2022 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role: Director
Signature: /s/ Alane P. Barnes, by power of attorney
Issuer symbol: BCRX
Transactions as of: 07 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2022, 16:50:14 UTC
Previous filing: 02 Jun 2022
Next filing: 13 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCRX	Common Stock	Award	$0	+12,866	+16%	$0.000000	95,004	07 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCRX	Automatic Stock Option Grant	Award	$0	+30,022		$0.000000	30,022	07 Jun 2022	Common Stock	30,022	$10.79	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
F2	Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.